Inicio / Estudios Omega-3 / 11. Omega-3 y piel


11. Omega-3 y piel

Brown ER, Subbaiah PV. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts. Lipids. 1994 Dec;29(12):825-9.
Gr�nn M, Christensen E, Hagve TA, Christophersen BO. The Zellweger syndrome: deficient conversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) and normal delta 4-desaturase activity in cultured skin fibroblasts. Biochim Biophys Acta. 1990 May 22;1044(2):249-54.
Kendall AC, Pilkington SM, Massey KA, Sassano G, Rhodes LE, Nicolaou A. �Distribution of Bioactive Lipid Mediators in Human Skin.� J Invest Dermatol. 2015 Feb 10. doi: 10.1038/jid.2015.41.
Kim HH, Cho S, Lee S, Kim KH, Cho KH, Eun HC, Chung JH. Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo. J Lipid Res. 2006 May;47(5):921-30. Epub 2006 Feb 7.
McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin Dermatol. 2010 Jul-Aug;28(4):440-51.
Okuda Y, Sawada T, Mizutani M, Sone H, Suzuki S, Kawakami Y, Soma M, Suzuki M, Yaoita H, Yamashita K. Restoration of myo-inositol uptake by eicosapentaenoic acid in human skin fibroblasts cultured in high-glucose medium. Life Sci. 1995;57(5):PL71-4.
Rosenthal MD, Whitehurst MC. Selective utilization of omega 6 and omega 3 polyunsaturated fatty acids by human skin fibroblasts. J Cell Physiol. 1982 Nov;113(2):298-306.
Shahbakhti H, Watson RE, Azurdia RM, Ferreira CZ, Garmyn M, Rhodes LE. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem Photobiol. 2004 Sep-Oct;80(2):231-5.
Ziboh VA, Miller CC, Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr. 2000 Jan;71(1 Suppl):361S-6S.






  • Entidades colaboradoras: